Company profile
Home
Santorini Scientific is an innovative company with the goal of 3D bio-printing the world's first transplantable human heart. Our project is based in Birmingham and we work in collaboration with partners all across the UK including in Bristol, London, New Castle and Nottingham.
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
Company registered at Companies House
1 Jun 2023 to 30 Nov 2023
Santorini Scientific, a small UK company, focuses on improving cardiac transplant outcomes. The objective of this project is to initiate successful application of a novel innovative T-cell therapy approach to manage post-transplant rejection. 10% of the 150,000 organ transplant patients annually succumb to rejection in the first three years after a transp...
1 Jan 2023 to 31 Dec 2026
no public description
